Literature DB >> 28026886

Haploidentical hematopoietic cell transplantation for disseminated Ewing sarcoma.

Hiroki Yoshihara1, Tadashi Kumamoto2, Rintaro Ono1, Keiko Akahane3, Taiki Nozaki4, Shogo Kobayashi5, Atsushi Kikuta5, Seiichi Matsumoto6, Daisuke Hasegawa1, Chitose Ogawa1, Atsushi Manabe1.   

Abstract

We describe the case of a 13-year-old girl with multifocal disseminated Ewing sarcoma family of tumor (ESFT) who received a 5/8 human leukocyte antigen-matched haploidentical hematopoietic cell transplantation to generate a graft-versus-tumor effect. The patient had grade 2 acute graft-versus-host disease (GVHD) of the skin and chronic GVHD nausea and abdominal pain that required prednisolone for 17 months, but has been free from ESFT for 3 years 10 months after therapy. The present case suggests a beneficial effect of haploidentical hematopoietic cell transplantation in disseminated ESFT.
© 2016 Japan Pediatric Society.

Entities:  

Keywords:  Ewing sarcoma; graft-versus-host disease; graft-versus-tumor effect; hematopoietic stem cell transplantation; killer cell immunoglobulin-like receptor

Mesh:

Year:  2016        PMID: 28026886     DOI: 10.1111/ped.13195

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  T-cell replete haploidentical stem cell transplantation with low dose anti-thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors.

Authors:  Hideki Sano; Kazuhiro Mochizuki; Shogo Kobayashi; Yoshihiro Ohara; Nobuhisa Takahashi; Shingo Kudo; Kazuhiko Ikeda; Hitoshi Ohto; Atsushi Kikuta
Journal:  Cancer Rep (Hoboken)       Date:  2021-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.